The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: BP boosted by lower-than-expected fine, ARM hit by Intel competition

Fri, 16th Jan 2015 12:53

Oil giant BP was among the risers after the company revealed it faces a maximum penalty of $13.7bn under the Clean Water Act. This follows the District Court for the Eastern District of Louisiana ruling on the Deepwater Horizon case, which found that 3.19m barrels of oil were discharged in the Gulf of Mexico in 2010. The bill, which was some $4bn less than feared, put the spill's size below the government's 4.09m estimate and just under the 3.26m estimated by the firm. Sector peer BHP Billiton was also up, after oil prices advanced on Friday morning. Brent futures were up 2.6% at $49.50 a barrel after the International Energy Agency (IEA) said a turnaround could be on the horizon. "A price recovery - barring any major disruption - may not be imminent, but signs are mounting that the tide will turn. A rebalancing may begin to occur in the second half of the year," the IEA said, as it lowered its forecasts for non-OPEC supply.Imperial Tobacco's share prices were boosted as Morgan Stanley hiked its target price from 2,680p to 3,250p and named the stock its new top pick, saying it is "increasingly optimistic" about its pending $7bn acquisition of assets from Reynolds and Lorillard.BT Group shares were also higher after being upgraded from 'hold' to 'buy' by Societe Generale.Meanwhile ARM Holdings took a hit after US chip rival Intel revealed it had sold more-than-expected chips for tablets in 2014 on Thursday night. Liberum kept a 'sell' rating on ARM, saying that competition from Intel is now rising in the smartphone sector, "which could take share from ARM in its core market".AstraZeneca was falling following a downgrade from Barclays Capital from 'equal weight' to 'underweight'. The broker said: "In an interview with The Times late last year CEO Pascal Soriot urged investors to not fixate on the Long-Range Plan central to its bid defence against Pfizer and to focus instead on margins. We view this as a tacit admission that management's $45 bn 2023 revenue projection is unrealistic and we view 2017 revenue guidance as equally unlikely to be met." RisersExperian (EXPN) 1,162.00p +3.66%Antofagasta (ANTO) 688.50p +2.76%BP (BP.) 403.40p +2.75%Glencore (GLEN) 247.05p +2.68%Anglo American (AAL) 1,087.00p +2.60%BG Group (BG.) 836.90p +2.01%BT Group (BT.A) 407.80p +1.90%BHP Billiton (BLT) 1,373.50p +1.89%Imperial Tobacco Group (IMT) 2,904.00p +1.89%Standard Life (SL.) 392.20p +1.24% FallerseasyJet (EZJ) 1,600.00p -2.74%Wolseley (WOS) 3,601.00p -2.54%Mondi (MNDI) 1,052.00p -2.41%Dixons Carphone (DC.) 424.30p -2.33%ARM Holdings (ARM) 974.00p -2.16%Babcock International Group (BAB) 1,003.00p -1.57%AstraZeneca (AZN) 4,661.50p -1.43%Burberry Group (BRBY) 1,661.00p -1.37%Persimmon (PSN) 1,436.00p -1.37%Meggitt (MGGT) 511.00p -1.35%
More News
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.